Varco Leg Care sells a wide range of leg care products addressing end-to-end leg health needs, targeting conditions such as varicose veins, diabetic foot, foot ulcers and restless leg syndrome. The company says it leverages technology and clinical expertise to manage leg health and has expanded distribution into organised retail (Guardian Pharmacy, Noble Plus, Wellness Forever) and online marketplaces (its website, Amazon, Flipkart, 1mg). Since its 2022 inception it reports serving more than 500,000 customers and placement in over 3,000 medical stores across Mumbai, Bangalore, Delhi and other Indian cities. The brand reported a 110% increase in revenue over the past year and says its valuation has doubled in the past 10 months (company did not disclose valuation figures). Varco plans to use the new capital to bolster offline touchpoints, advance R&D initiatives, and scale and optimize marketing efforts. Varco Leg Care develops plant-molecule-based topical agents and capsules to treat varicose veins, spider veins, diabetic foot, and restless leg syndrome. Founded in 2022 and based in Delhi, the company says it has served more than 3 lakh customers and grown to over 1,500 pharmacies across Delhi, Mumbai, and Bengaluru. Varco reports over $1 million in net revenue and aims to grow its monthly recurring revenue tenfold. It raised Rs 2 crore in a bridge funding round led by Neeraj Garg to support R&D, treatment adherence programs, retail expansion, talent acquisition, and customer retention initiatives. The company plans expansion into GCC markets and is building a comprehensive product portfolio to strengthen its position in the U.S. through strategic partnerships with leading marketplaces. The core offering combines topical agents and oral capsules using plant molecule technology to improve treatment efficacy.

Total raised

$1M

Funding rounds

2

Latest round

Seed

Latest activity

Apr 2024